Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study.

Journal: EClinicalMedicine

Volume: 69

Issue: 

Year of Publication: 

Affiliated Institutions:  Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. ICES uOttawa, Ottawa, Ontario, Canada.

Abstract summary 

There is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. In this study we estimated the risk of having an incident healthcare visit for an anxiety disorder following an emergency department (ED) visit for cannabis use and explored factors associated with increased risk.We used health administrative data to perform a population-based cohort study of all individuals aged 10-105 years with no previous healthcare visits for anxiety disorders in Ontario, Canada, between January 2008 and March 2019. We compared the risk of having an incident healthcare visit for an anxiety disorder in the ED or hospital (primary analysis) or additionally in an outpatient setting (secondary analysis) for individuals with an incident ED visit for cannabis to members of the general population using cumulative incidence functions and cause-specific hazard models adjusted for relevant confounders.Our study included 12,099,144 individuals aged 10-105 without prior care for an anxiety disorder in the ED or hospital, of which 34,822 (0.29%) had an incident ED visit due to cannabis. Within 3-years of an incident ED visit due to cannabis, 12.3% (n = 4294) of individuals had an incident ED visit or hospitalization for an anxiety disorder-a 3.7-fold (adjusted Hazard Ratio [aHR] 3.69 95% CI 3.57-3.82) increased risk relative to the general population (1.2%). In secondary analysis, further excluding individuals with prior outpatient care for anxiety disorders, 23.6% of individuals with an ED visit due to cannabis had an incident outpatient visit, ED visit, or hospitalization for an anxiety disorder within 3-years compared to 5.6% of individuals in the general population (aHR 3.88 95% CI 3.77-2.99). The risk of having an incident healthcare visit for an anxiety disorder was higher in individuals with ED visits for cannabis use compared to the general population across all age and sex strata. However, younger males with ED visits for cannabis use (aHR 5.67 95% CI 5.19-6.21) had a greater risk relative to the general population than younger women with cannabis use (aHR 3.22 95% CI 2.95-3.52).ED visits for cannabis use were associated with an increased risk of having an incident healthcare visit for an anxiety disorder, particularly in young males. These findings have important clinical and policy implications given the increasing use of cannabis over time and trend towards legalization of cannabis.Canadian Institutes for Health Research.

Authors & Co-authors:  Myran Harrison Pugliese Tanuseputro Gaudreault Fiedorowicz Solmi

Study Outcome 

Source Link: Visit source

Statistics
Citations :  United Nations Office on Drugs and Crime World drug report 2022. 2022. https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html [cited 2023 Jul 27]. Available from:
Authors :  7
Identifiers
Doi : 102455
SSN : 2589-5370
Study Population
Males,Women
Mesh Terms
Other Terms
Anxiety;Anxiety disorder;Cannabis;Cannabis use disorder;Cohort study;Health administrative data
Study Design
Cohort Study
Study Approach
Country of Study
Publication Country
England